Economic Evaluation of Delivering Hepatitis B Vaccine to Injection Drug Users
Hu Y, Grau LE, Scott G, Seal KH, Marshall PA, Singer M, Heimer R. Economic Evaluation of Delivering Hepatitis B Vaccine to Injection Drug Users. American Journal Of Preventive Medicine 2008, 35: 25-32. PMID: 18541174, PMCID: PMC2483306, DOI: 10.1016/j.amepre.2008.03.028.Peer-Reviewed Original ResearchConceptsInjection drug usersSyringe exchange programsHBV vaccinationDrug usersHepatitis B vaccination coverageActive injection drug usersAcute HBV infectionHepatitis B infectionHepatitis B vaccineQuality-adjusted life yearsAbsence of vaccinationLocal health departmentsDifferent vaccination strategiesVaccination program costsB infectionHBV infectionB vaccineFirst doseVaccination scheduleVaccination coverageVaccination strategiesCost-saving strategyVaccination campaignHigh riskMedical costsHepatitis B Virus Prevalence and Vaccination Rates among Hispanic Injection Drug Users Participating in a Vaccination Campaign
Heimer R, Grau L, Singer M, Scott G, Marshall P, Hu Y, Seal K. Hepatitis B Virus Prevalence and Vaccination Rates among Hispanic Injection Drug Users Participating in a Vaccination Campaign. Journal Of Drug Issues 2008, 38: 335-350. DOI: 10.1177/002204260803800114.Peer-Reviewed Original ResearchInjection drug usersVaccination ratesDrug usersHepatitis B virus (HBV) prevalencePast hepatitis B infectionHepatitis B virus infectionHispanic injection drug usersHepatitis B infectionHepatitis B vaccinationB virus infectionDoses of vaccineNon-Hispanic blacksCurrent drug useSyringe exchange programsNon-Hispanic whitesB vaccinationB infectionHepatitis infectionHepatitis BEffective vaccineVirus infectionStudy populationVaccination campaignHigh riskDrug use